Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Henry Khederian

HISTORICAL FACTS: Why kala pharmaceuticals shares are rising today - Caught on Camera

Kala Pharmaceuticals Inc (NASDAQ:KALA) shares are trading higher after the company said it would sell its EYSUVIS and INVELTYS treatments for $60 million.

Kala Pharmaceuticals is selling its commercial portfolio and related intellectual property assets to Alcon. Kala says the company will receive $60 million in an upfront payment and is eligible to receive additional sales-based milestone payments.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.